Breast Imaging Technologies Market Size & Share, by Technology (3D Digital Mammography, 2D Digital Mammography, Breast Ultrasound, Breast MRI, Molecular Breast Imaging); Product; Application; End user - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2034

Breast Imaging Technologies Market - Regional Analysis

North America Market Insights

North America is striving to maintain its dominance in the breast imaging technologies industry, grabbing the largest share of 42.6% with a 7.9% growth rate during the forecast timeline. The region’s leadership is attributed to the rapid AI integration and favorable reimbursement policies. About 65.4% of the mammography systems in the U.S. are anticipated to incorporate AI in diagnostics by 2026. Besides, the AMA 2024 report notes that private insurers are offering coverage to 92.6% of advanced imaging expenses in the country, benefiting both service providers and consumers.

The breast imaging technologies market in the U.S. is readily dominating the overall North America region, highly fueled by FDA-cleared algorithms and healthcare grants from prominent systems. In this context, CMS reports that Medicare reimbursement for 3D mammography surpassed USD 820.6 million in 2024, whereas Medicaid successfully enhanced its coverage to 12.3% more patients, reflecting a strong financial backup. Besides the CDC’s NBCCEDP program granted USD 300 million for the underprivileged population, hence reducing disparities and inducing progress in the market.

The market in Canada is effectively propelled by public healthcare coverage facilities and provincial screening mandates. In this context, Ontario’s investment has been enhanced by a significant 19.5% in digital mammography, whereas federal funding reached USD 3.4 billion in 2024, with a prime focus on rural areas. Also, the country witnessed the AI-based ultrasound adoption rise by 26.4% in British Columbia, showcasing the increased market demand. In addition, public reimbursement offers coverage to 86.3% of screenings, ensuring affordability, thus a positive market outlook.

Europe Market Insights

Europe in the breast imaging technologies market accounts for 28.6% of the worldwide revenue by the end of the forecast period. The upliftment in the region is effectively propelled by nationwide screening mandates and funding grants. Exemplifying this, Europe’s Beating Cancer Plan in 2021 allocated €2.6 billion for early detection, where 3D mammography coverage has been expanded to 92% of public healthcare systems. Besides, the presence of leading countries and their unique developmental approaches readily bolsters the market growth internationally.

The market in Germany remains the largest market in Europe, which is highly fueled by the unprecedented public investment and technological innovations. In this regard, the Federal Ministry of Health made an investment of €1.2 billion towards the Digital Radiology Initiative from the tenure 2024 to 2027 that specifically targets AI integration in breast imaging, out of which 40.4% of funds were allocated to upgrade existing mammography systems. Besides, Siemens Healthineers' R&D center has filed 45 patents for breast imaging AI in 2023, thus reflecting the country’s captivity over the landscape.

France is portraying steady growth in the breast imaging technologies market owing to the comprehensive policy reforms, strategic partnerships, and decentralized access. In this regard, the 2024 Plan Cancer III imposed a mandatory 90% reimbursement for 3D mammography, wherein €422.4 million was allocated to replace analog systems across the nation’s vast geography. On the other hand, Hologic announced a collaboration with Gustave Roussy Institute, which developed an AI-based screening center, reducing the diagnostic duration from 14 days to 11 days, thus fostering a favorable business environment.

Country-wise Government Provisions

APAC Market Insights

The breast imaging technologies market in Asia Pacific is predicted to demonstrate the fastest growth on account of rising breast cancer burden and government-backed screening mandates. In this context World Health Organization study states that around 1.6 million new yearly cases are diagnosed in the region, highlighting the presence of a reliable consumer base. Besides the exclusive reimbursement reforms along with mammography adoption will further propel progress in this landscape, allowing a steady cash influx.

China is the dominating player in the regional as well as global market, which is highly fueled by the presence of the Healthy China 2030 initiative, which allocated $2.9 billion for digital mammography upgrades in public hospitals. Besides, NHC in 2023 reported that the breast cancer screening rate in the country is at a boom, reaching 65.7% in urban areas, and is supported by portable units deployed in rural clinics. Furthermore, the fast-track policy has successfully accelerated approvals for 12 new imaging devices.

India is emerging in the breast imaging technologies industry, owing to the aspect of the Ayushman Bharat rollout for 5,000 portable breast ultrasound units in rural areas as of NHP 2024 data. Due to the persistent healthcare disparities, the 2023 National Cancer Grid initiative aims to bridge gaps by offering subsidies to 50.6% of digital mammography costs for 10 million women by the end of 2026. On the other hand, the domestic manufacturing capabilities are at a surge with Trivitron Healthcare launching the first-ever AI-integrated mammography system in the country in 2024, priced 40% lower than imports.

Country-wise Government Provisions